Comunicati Stampa
Salute e Benessere

One2Treat, the leading company incorporating the patient voice into clinical development, launches One2Treat Voice app

This strategic development supports One2Treat's mission to transform how clinical trials are designed and how treatment value is assessed, anchoring every decision in the perspective of what matters most for patients. This strategic development supports One2Treat's mission to transform how clinical trials are designed and how treatment value is assessed, anchoring every decision in the perspective of what matters most for patients. "This past year has shown that patient-centricity and...
Belgium, (informazione.news - comunicati stampa - salute e benessere)

This strategic development supports One2Treat's mission to transform how clinical trials are designed and how treatment value is assessed, anchoring every decision in the perspective of what matters most for patients.

One2Treat has officially launched One2Treat Voice, a software module designed to capture and prioritize inputs from patients, clinicians, regulatory bodies and clinical trial sponsors. The result is a structured, data-driven prioritization of clinical outcomes, enabling the definition of multi-dimensional primary endpoints using the Net Treatment Benefit (NTB) methodology.

One2Treat Voice may also help physicians and patients express what matters most to them, leading to a clearer decision about the most appropriate approved treatment – based on past randomized clinical trial data.

One2Treat Voice is part of a broader cloud-based platform that supports strategic decision-making throughout the clinical development process, from protocol design to data analysis. The platform empowers sponsors to assess the totality of the evidence and understand the overall medical value of a treatment. One2Treat's platform is also used to support trial design, go/no-go decisions, dose selection, market access planning, and commercialization based on patient-and clinician-prioritized outcomes.

One2Treat is a fast-growing tech company incorporating the patient voice in all strategic decisions about treatment assessments in Pharma R&D. One2Treat is dedicated to transforming the way biopharmaceutical companies design and evaluate clinical trials, and how the overall medical value of a treatment may be communicated, by integrating multiple meaningful dimensions in the treatment assessment

For more information about One2Treat and its innovative approach to clinical development and market access, please visit: www.one2treat.com.

View original content:https://www.prnewswire.co.uk/news-releases/one2treat-the-leading-company-incorporating-the-patient-voice-into-clinical-development-launches-one2treat-voice-app-302483734.html

Ufficio Stampa
 PR Newswire (Leggi tutti i comunicati)
209 - 215 Blackfriars Road
LONDON United Kingdom
Allegati
Non disponibili